Panagora Asset Management Inc. Cuts Stock Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

Panagora Asset Management Inc. cut its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 84.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,809 shares of the company’s stock after selling 124,908 shares during the period. Panagora Asset Management Inc.’s holdings in Nu Skin Enterprises were worth $1,174,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. BlackRock Inc. increased its stake in Nu Skin Enterprises by 19.5% during the first quarter. BlackRock Inc. now owns 7,498,023 shares of the company’s stock worth $358,856,000 after purchasing an additional 1,224,725 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Nu Skin Enterprises by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock worth $69,442,000 after buying an additional 38,282 shares in the last quarter. Acadian Asset Management LLC grew its position in shares of Nu Skin Enterprises by 29.5% during the first quarter. Acadian Asset Management LLC now owns 615,706 shares of the company’s stock worth $29,466,000 after buying an additional 140,367 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its position in shares of Nu Skin Enterprises by 6.0% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 576,970 shares of the company’s stock worth $28,456,000 after buying an additional 32,570 shares in the last quarter. Finally, Delek Group Ltd. grew its position in shares of Nu Skin Enterprises by 53.0% during the second quarter. Delek Group Ltd. now owns 573,900 shares of the company’s stock worth $27,653,000 after buying an additional 198,900 shares in the last quarter. Institutional investors own 73.95% of the company’s stock.

A number of equities analysts have recently commented on the company. Jefferies Financial Group downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating and set a $40.00 price objective for the company. in a research report on Wednesday, July 17th. Bank of America reissued an “underperform” rating and set a $52.00 price objective (down from $57.00) on shares of Nu Skin Enterprises in a research report on Wednesday, June 19th. Pivotal Research reissued a “buy” rating and set a $70.00 price objective on shares of Nu Skin Enterprises in a research report on Wednesday, August 7th. DA Davidson boosted their price objective on Nu Skin Enterprises to $42.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Citigroup lowered their price objective on Nu Skin Enterprises from $86.00 to $52.00 and set a “buy” rating for the company in a research report on Thursday, July 18th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $53.75.

NUS traded up $0.36 on Thursday, reaching $44.41. The company’s stock had a trading volume of 26,485 shares, compared to its average volume of 683,398. The stock has a 50 day moving average of $40.56 and a two-hundred day moving average of $48.47. The company has a quick ratio of 1.20, a current ratio of 1.90 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of 12.59, a P/E/G ratio of 1.42 and a beta of 0.77. Nu Skin Enterprises, Inc. has a fifty-two week low of $35.03 and a fifty-two week high of $85.75.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.83 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.83. The firm had revenue of $623.50 million during the quarter, compared to the consensus estimate of $622.32 million. Nu Skin Enterprises had a return on equity of 24.73% and a net margin of 4.79%. The firm’s quarterly revenue was down 11.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.95 earnings per share. As a group, analysts anticipate that Nu Skin Enterprises, Inc. will post 3.26 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 11th. Investors of record on Friday, August 30th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 3.33%. The ex-dividend date was Thursday, August 29th. Nu Skin Enterprises’s dividend payout ratio (DPR) is 42.05%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Story: Trading signals using Bollinger bands

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply